TNYA Tenaya Therapeutics Inc
Company Analysis
Latest News
🔴 Tenaya Therapeutics is trading 10.4% down today as biotech ETF XBI fell 5.19%
Tenaya Therapeutics is trading at $0.33, down 10.4%, amid broad risk-off pressure. - At 12:33 p.m. EST, XBI was reported down 5.19%, alongside sharp declines...
🔴 Tenaya Therapeutics is trading 5% down amid Nasdaq and S&P losses
Tenaya Therapeutics is trading at $0.34, down 5.11%, on November 5, 2026, amid a broad risk-off session. - The Nasdaq Composite fell 3.23% and the S&P 500 fell...
Tenaya Therapeutics Beats Q3 Estimates and Rallies 8%, but Can a $67 Million Cash Pile Carry an Unproven Heart-Disease Pipeline to the Finish Line?
Shares shifted as Tenaya Therapeutics jumped 8.3% to $0.40 after delivering a third-quarter earnings surprise that, for a clinical-stage biotech burning cash,...
🟢 Tenaya Therapeutics is trading 8.27% up in pre-market after Q3 loss narrowed and revenue topped expectations
Tenaya Therapeutics is trading at $0.40, up 8.27%, after its third-quarter results beat expectations. - In its November 4 report, the company posted a narrower...
Tenaya Therapeutics narrows third quarter 2026 net loss to $0.08 per share as FDA grants RMAT designation
Tenaya Therapeutics reported collaboration revenue of $1.7 million for the third quarter of 2026, compared to no revenue in the prior year period. The...
🟢 Tenaya Therapeutics is trading 5% up today as biotech and broader markets rise
Tenaya Therapeutics is trading at $0.38, up 5.41%, with broader biotech and market strength the likeliest explanation, though no source directly attributes the...
🟢 Tenaya Therapeutics is trading 11% up in pre-market
Tenaya Therapeutics is trading 11.02% higher at $0.41 in pre-market on November 2, 2026, versus the October 30 close of $0.37; no clear new company...
🔴 Tenaya Therapeutics is trading 6.9% down with no clear catalyst identified
Tenaya Therapeutics is trading 6.9% down at $0.37 on October 30, 2026; the reason for the decline remains unclear. - The provided price context shows a...
🟢 Tenaya Therapeutics is trading 6% up today with no clear company-specific catalyst
Tenaya Therapeutics is trading 6.07% higher at $0.41 on October 26, 2026, with no clear company-specific announcement explaining the move. - The S&P 500 is up...
🟢 Tenaya Therapeutics is trading 11% up today as biotech stocks gain
Tenaya Therapeutics is trading at $0.42 (+10.78%), with biotech-sector strength the strongest available explanation; no company-specific catalyst was...
🟢 Tenaya Therapeutics is trading 5% up today amid a biotech-sector rally
Tenaya Therapeutics is trading at $0.40, up +5.03%, alongside a biotech-sector rally; this offers a sector-level explanation, not a confirmed company...
🔴 Tenaya Therapeutics falls 5.4% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🟢 Tenaya Therapeutics is trading 5% up with no confirmed company-specific catalyst
Tenaya Therapeutics is trading 5.02% up at $0.42, with no confirmed company-specific announcement or catalyst identified for the gain. - The reported price...
🟢 Tenaya Therapeutics is trading 7.1% up in pre-market with no confirmed catalyst
Tenaya Therapeutics is trading 7.14% higher at $0.42 in pre-market on October 15, 2026; no confirmed company-specific catalyst for the rise was identified. -...
🟢 Tenaya Therapeutics is trading 8.58% up in after-hours trading with no confirmed company-specific catalyst
Tenaya Therapeutics is trading at $0.42, up 8.58% in after-hours trading, with no confirmed company-specific catalyst identified. - A preliminary proxy filing...
🔴 Tenaya Therapeutics is trading 15.5% down — no confirmed catalyst identified
Tenaya Therapeutics is trading 15.5% down at $0.42, and no confirmed company-specific catalyst for the October 14 move was identified. - An October 14 Form PRE...
🔴 Tenaya Therapeutics is trading 5% down with no confirmed company-specific catalyst
Tenaya Therapeutics is trading 5.02% down at $0.54 on October 13, 2026, with no verified company-specific announcement or event explaining the decline. -...
🔴 Tenaya Therapeutics is trading 5% down today — no verified catalyst identified
On October 12, 2026, Tenaya Therapeutics is trading 5.17% lower at $0.55; no verified company-specific catalyst explaining the decline has been identified. -...
🟢 Tenaya Therapeutics rises 5.1% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Tenaya Therapeutics is trading 5% down with no confirmed catalyst
Tenaya Therapeutics is trading 5.14% lower now at $0.57; the cause of the October 1, 2026 decline remains unconfirmed. - No company-specific announcement or...